Rheumatic immune-related adverse events from cancer immunotherapy

Nature Reviews. Rheumatology
L H CalabreseLaura C Cappelli

Abstract

Immunotherapy has revolutionized the treatment of cancer, but a rapid rise in the use of the family of therapeutic agents known as checkpoint inhibitors (CPIs) is associated with a new group of immune-related adverse events (irAEs) in almost any organ system. Among these irAEs, rheumatic complications are common and seem to have features that are distinct from irAEs in other organ systems, including a highly variable time of clinical onset and the capacity to persist, possibly indefinitely, even after cessation of CPI therapy. In this Review, mechanisms of action of CPIs and how they might cause rheumatic irAEs are described. Also covered are epidemiology and clinical descriptions of rheumatic irAEs, plus guiding principles for managing irAEs. Finally, we outline future directions that must be taken in response to a series of unanswered questions and unmet needs that now confront rheumatologists who are, or will be, engaged in this new area of rheumatology.

References

Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter AttiaSteven A Rosenberg
Jul 10, 2009·The New England Journal of Medicine·Fouad FadelBertrand Knebelmann
Aug 5, 2009·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Gary HunterChristopher A Robinson
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jul 9, 2011·Nature Immunology·E John Wherry
Jun 5, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David R MinorJudith Doyle
Oct 16, 2013·Journal of the American Academy of Dermatology·Ross B Reule, Jeffrey P North
Dec 18, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Marloes J M Olde NordkampLinde Meyaard
Apr 4, 2014·Science Translational Medicine·Shintaro IwamaPatrizio Caturegli
Jul 24, 2014·The New England Journal of Medicine·Richard S Hotchkiss, Lyle L Moldawer
Oct 29, 2014·Journal for Immunotherapy of Cancer·Chrisann KyiMichael A Postow
Nov 22, 2014·Journal of Immunotherapy·Matthew M K ChanNicholas Manolios
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael A PostowJedd D Wolchok
Apr 4, 2015·Science·Padmanee Sharma, James P Allison
Jun 25, 2015·The Journal of Dermatology·Miri YoshiokaHiroyuki Matsue
Sep 9, 2015·The New England Journal of Medicine·Antoni Ribas
Feb 15, 2016·Cancer Treatment Reviews·Lavinia SpainJames Larkin
Mar 12, 2016·Nature Reviews. Drug Discovery·Axel Hoos
Apr 29, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G MansonR Houot
May 5, 2016·Nature Reviews. Clinical Oncology·Celine BoutrosCaroline Robert
Jun 17, 2016·Annals of the Rheumatic Diseases·Laura C CappelliClifton O Bingham
Jul 16, 2016·Cancer Science·Toshihiro KimuraHironobu Ihn
Aug 20, 2016·Nature Reviews. Rheumatology·Michiel van der VlistLinde Meyaard
Aug 28, 2016·Annals of the Rheumatic Diseases·Leonard Calabrese, Vamsidhar Velcheti
Oct 9, 2016·The New England Journal of Medicine·Alexander M M EggermontAlessandro Testori
Nov 3, 2016·The New England Journal of Medicine·Douglas B JohnsonJavid J Moslehi
Nov 3, 2016·The New England Journal of Medicine·Vassiliki A Boussiotis
Nov 29, 2016·Rheumatic Diseases Clinics of North America·Laura C CappelliClifton O Bingham
Dec 27, 2016·Frontiers in Immunology·Kankana BardhanVassiliki A Boussiotis
Jan 10, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey S WeberCaroline Robert
Jan 14, 2017·Arthritis & Rheumatology·Maria E Suarez-AlmazorAdi Diab
Jan 25, 2017·Proceedings of the National Academy of Sciences of the United States of America·Hui ZhangCornelia M Weyand
Feb 28, 2017·Journal for Immunotherapy of Cancer·Eileen ShiuanDouglas Johnson

❮ Previous
Next ❯

Citations

Jan 11, 2020·Current Opinion in Rheumatology·Leonard H Calabrese, Cassandra Calabrese
Jan 5, 2020·Annals of the Rheumatic Diseases·Leonard Calabrese, Xavier Mariette
Mar 14, 2020·Current Opinion in Rheumatology·Susanna Jeurling, Laura C Cappelli
May 3, 2020·International Journal of Molecular Sciences·Antonio G SolimandoVito Racanelli
May 20, 2020·Scandinavian Journal of Rheumatology·S Kobak
Apr 5, 2020·Nature Reviews. Clinical Oncology·Khashayar EsfahaniLeonard Calabrese
Jul 12, 2019·Frontiers in Oncology·Caoilfhionn ConnollyJarushka Naidoo
Nov 26, 2019·Thoracic Cancer·Jiaxin ZhouLi Zhang
Jun 24, 2020·Journal for Immunotherapy of Cancer·William Murray-BrownMihir D Wechalekar
Aug 25, 2020·Journal of Immunology Research·Yan XiaoWeirong Yao
Apr 25, 2019·The Korean Journal of Internal Medicine·Kyung-Ann LeeSo Young Yoon
May 15, 2020·International Journal of Molecular Sciences·Konstantinos MelissaropoulosDimitrios Daoussis
Jul 28, 2020·Asia-Pacific Journal of Clinical Oncology·Hui ZhongXiaofeng Zeng
Nov 30, 2019·Case Reports in Rheumatology·Bicky ThapaCassandra Calabrese
Dec 4, 2019·Journal of Oncology Practice·Haesoo KimAndrew E Hendifar
Aug 11, 2020·Expert Review of Clinical Immunology·Sandra G WilliamsSarthak Gupta
Nov 26, 2020·Nature Reviews. Rheumatology·Laura C Cappelli, Clifton O Bingham
Nov 2, 2019·La Revue de médecine interne·T ComontO Lambotte
Nov 18, 2020·Cancer Immunology, Immunotherapy : CII·Zhe ZhaoDan Zhang
Dec 9, 2020·Advanced Materials·Mengyu ChangJun Lin
Jan 28, 2021·Biomedicines·Izabela KarwackaKrzysztof Sworczak
Nov 25, 2020·Cancers·Maria-Carlota Londoño On Behalf Of The Retoinmuno Multidisciplinary Group
Jan 5, 2021·Journal of the American College of Emergency Physicians Open·Sai-Ching Jim YeungKumar Alagappan
Jan 16, 2021·European Journal of Immunology·Zena N WillsmoreSophia N Karagiannis
Nov 14, 2020·Arthritis & Rheumatology·Laura C Cappelli, Clifton O Bingham
Mar 23, 2021·Expert Opinion on Drug Safety·Remo PotoGilda Varricchi
Mar 17, 2021·Rheumatology·Amandine WeillUNKNOWN Groupe de Cancérologie Cutanée and PATIO Group
Apr 28, 2021·Bulletin du cancer·Thomas TingryCyrille B Confavreux
May 27, 2021·Med·Joanna RoopkumarAlok A Khorana
Jun 5, 2021·International Journal of Cancer. Journal International Du Cancer·Wenfeng LiuWenbo Zhu
Sep 1, 2021·Rheumatology·Manil SubesingheSujith Subesinghe

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.